It is almost certain that he won't listen, unless the exceedingly improbable happens, and we make him. Given that it appears that the great majority of Imugene shareholders might be described as d - - - - - - s w - - - - - s, Hopper will continue to have licence to rape and pillage!!! For mine, it will mean I make a lot less money. For cancer patients, the delivery of successful drugs to market (and to tumors) will probably be sub-optimal. It really is a tragedy that IMU's BOD is ethically challenged, there are plenty of BODs that are able to represent all stakeholders with competence and fairness. Strictly my opinions only. DYOR.
IMU Price at posting:
11.8¢ Sentiment: Buy Disclosure: Held
